APA (7th ed.) Citation

Putzu, C., Serra, R., Campus, R., Fadda, G. M., Sini, C., Marongiu, A., . . . Paliogiannis, P. (2024). Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy. Current Oncology, 31(9), 4955. https://doi.org/10.3390/curroncol31090367

Chicago Style (17th ed.) Citation

Putzu, Carlo, et al. "Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy." Current Oncology 31, no. 9 (2024): 4955. https://doi.org/10.3390/curroncol31090367.

MLA (9th ed.) Citation

Putzu, Carlo, et al. "Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy." Current Oncology, vol. 31, no. 9, 2024, p. 4955, https://doi.org/10.3390/curroncol31090367.